Search results
Financing Global Health 2023: The Future of Health Financing in the Post-Pandemic Era
Financing Global Health 2023 looks at how interest payments on loans that many countries took out during the COVID-19 pandemic to keep their economies afloat and their people protected are now straining health budgets.
FGH 2023: Non-communicable diseases
Development assistance for NCDs dropped by 34.4% between 2020 and 2023.
FGH 2023: Malaria
Development assistance for malaria amounted to $3.3 billion in 2023.
FGH 2023: Pandemic preparedness and response
Development assistance for health for pandemic preparedness and response peaked in 2020 at over $1 billion.
FGH 2023: HIV/AIDS
Funding for HIV/AIDS reached an all-time high of $14.1 billion in 2023.
A burden of proof study on alcohol consumption and ischemic heart disease
We conducted an updated systematic review and re-evaluated existing cohort, case-control, and Mendelian randomization data using the burden of proof meta-analytical framework.
Financing Global Health
Explore patterns of global health financing flows from 1990 to 2050.
Ascariasis
Appendicitis
Aortic aneurysm
Anorexia nervosa
Amphetamine use disorder
Alzheimer’s disease and other dementias
Alcoholic cardiomyopathy
Alcohol use disorders
Acute hepatitis
Acute glomerulonephritis
FGH 2023: Tuberculosis
Development assistance for tuberculosis dropped by 3.3% between 2017 and 2021, but rose again in 2022 to $2.6 billion.
FGH 2023: Reproductive, maternal, newborn, and child health
Over the last decade, development assistance for reproductive, maternal, newborn, and child health has grown by 18.2%.
Differences across the lifespan between females and males in the top 20 causes of disease burden globally
We aim to quantify differences in the leading causes of disease burden between females and males across ages and geographies.